ConductScience.org, home

Paper39606232

The role of miR-152 in urological tumors: potential biomarkers and therapeutic targets.

Li X and 6 others. Front Immunol, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. The role of miR-152 in urological tumors: potential biomarkers and therapeutic targets. Papers, record 39606232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39606232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The role of miR-152 in urological tumors: potential biomarkers and therapeutic targets.
PubMed
Journal
Front Immunol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.75, provisional
iCite
Revised in PubMed
2026-10-15
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li XXin
2Qian BBiao
3Chen XXu
4Shen MMaolei
5Zhao SShankun
6Zhang XXinsheng
7He JJian

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MicroRNAsMajor topic
Biomarkers, TumorMajor topic
Gene Expression Regulation, NeoplasticMajor topic
Urologic NeoplasmsMajor topic
Humans
Male
Animals
Prostatic Neoplasms
Urinary Bladder Neoplasms

Source PubMed

Download CSV of topics

References130

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134936728METTL1-m7 G-EGFR/EFEMP1 axis promotes the bladder cancer development.Clin Transl Med2021https://conductscience.org/library/papers/34936728PubMed
225190353MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2.Exp Mol Med2014https://conductscience.org/library/papers/25190353PubMed
335236289miR-152-3p impedes the malignant phenotypes of hepatocellular carcinoma by repressing roundabout guidance receptor 1.Cell Mol Biol Lett2022https://conductscience.org/library/papers/35236289PubMed
429723452[Circulating miR-152 helps early prediction of postoperative biochemical recurrence of prostate cancer].Zhonghua Nan Ke Xue2017https://conductscience.org/library/papers/29723452PubMed
520146264MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes.Hepatology2010https://conductscience.org/library/papers/20146264PubMed
633405070Lumasiran: First Approval.Drugs2021https://conductscience.org/library/papers/33405070PubMed
731038865lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion.Int Braz J Urol2019https://conductscience.org/library/papers/31038865PubMed
833732021LncRNA HCG18 Promotes Clear Cell Renal Cell Carcinoma Progression by Targeting miR-152-3p to Upregulate RAB14.Cancer Manag Res2021https://conductscience.org/library/papers/33732021PubMed
937625835miR-152-3p Inhibits Proliferation, Invasion and Autophagy in UMUC3 and TCCSUP Bladder Cancer Cell Lines via Suppressing HMGA2 Expression.Ann Clin Lab Sci2023https://conductscience.org/library/papers/37625835PubMed
1012198168MicroRNA maturation: stepwise processing and subcellular localization.EMBO J2002https://conductscience.org/library/papers/12198168PubMed
1123460133miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines.Prostate2013https://conductscience.org/library/papers/23460133PubMed
1233500248A lncRNA TCL6-miR-155 Interaction Regulates the Src-Akt-EMT Network to Mediate Kidney Cancer Progression and Metastasis.Cancer Res2021https://conductscience.org/library/papers/33500248PubMed
1323958847MicroRNA signature helps distinguish early from late biochemical failure in prostate cancer.Clin Chem2013https://conductscience.org/library/papers/23958847PubMed
1421221794miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42.Dig Dis Sci2011https://conductscience.org/library/papers/21221794PubMed
1535907137TMEM97 is transcriptionally activated by YY1 and promotes colorectal cancer progression via the GSK-3β/β-catenin signaling pathway.Hum Cell2022https://conductscience.org/library/papers/35907137PubMed
1638223603Expression of miR-152 in cervical cancer and its influence on cisplatin resistance.Afr Health Sci2023https://conductscience.org/library/papers/38223603PubMed
1738572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1826155421Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma.Oncoimmunology2015https://conductscience.org/library/papers/26155421PubMed
1915531879Processing of primary microRNAs by the Microprocessor complex.Nature2004https://conductscience.org/library/papers/15531879PubMed
2030845775Assessment of miR-98-5p, miR-152-3p, miR-326 and miR-4289 Expression as Biomarker for Prostate Cancer Diagnosis.Int J Mol Sci2019https://conductscience.org/library/papers/30845775PubMed

See all 130 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
41462933Differentially Expressed miRNA of Prostate Cancer Compared with Benign Prostatic Hyperplasia Tissues: VAMP Associated Protein B Could Be Used for New Targets and Biomarkers of Prostate Cancer.Biomedicines2025https://conductscience.org/library/papers/41462933PubMed
40643721Regulation and function of microRNA-152 in various types of cancers: its upstream regulators and downstream targets.Clin Exp Med2025https://conductscience.org/library/papers/40643721PubMed
40309956Mechanism of microRNA-152 Regulating Decidual Natural Killer Cell Viability and Affecting Trophoblast Cell Invasiveness via the HLA-G/KIR2DL4 Axis.Kaohsiung J Med Sci2025https://conductscience.org/library/papers/40309956PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MIR152406943PubTator's text mininghttps://conductscience.org/library/genes/406943

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39606232

GET https://conductscience.org/api/papers/v1/39606232/references?page=2